APA

Francis D. L., Visvikis D., Costa D. C., Arulampalam T. H. A., Townsend C., Luthra S. K., Taylor I. & Ell P. J. (20031217). Potential impact of [18F]3'-deoxy-3'-fluorothymidine versus [18F]fluoro-2-deoxy-D-glucose in positron emission tomography for colorectal cancer. : European journal of nuclear medicine and molecular imaging.

Chicago

Francis D L, Visvikis D, Costa D C, Arulampalam T H A, Townsend C, Luthra S K, Taylor I and Ell P J. 20031217. Potential impact of [18F]3'-deoxy-3'-fluorothymidine versus [18F]fluoro-2-deoxy-D-glucose in positron emission tomography for colorectal cancer. : European journal of nuclear medicine and molecular imaging.

Harvard

Francis D. L., Visvikis D., Costa D. C., Arulampalam T. H. A., Townsend C., Luthra S. K., Taylor I. and Ell P. J. (20031217). Potential impact of [18F]3'-deoxy-3'-fluorothymidine versus [18F]fluoro-2-deoxy-D-glucose in positron emission tomography for colorectal cancer. : European journal of nuclear medicine and molecular imaging.

MLA

Francis D L, Visvikis D, Costa D C, Arulampalam T H A, Townsend C, Luthra S K, Taylor I and Ell P J. Potential impact of [18F]3'-deoxy-3'-fluorothymidine versus [18F]fluoro-2-deoxy-D-glucose in positron emission tomography for colorectal cancer. : European journal of nuclear medicine and molecular imaging. 20031217.